$金斯瑞生物科技(01548)$
$腾讯控股(00700)$
$恒瑞医药(SH600276)$
1548.HK金斯瑞子公司南京传奇脚踏实地、货真价实、让我对她的使命、承诺、发展成为像苹果一样的伟大公司造福全人类一如既往充满信心，现在更加坚定！
 
Legend Biotech Corporation is an R&D based biotech company dedicated to immunotherapy, specifically CAR-T cell therapy. Our goal is to explore and deliver safe, effective and precision immunotherapies to desperate cancer patients. We swear to use all our intelligence and efforts to help people beat cancer. We explore every potential to improve the quality of life and survival of cancer patients, relieving them from suffering agony and desperation.
 
传奇生物技术公司是一家致力于免疫治疗特别是从事CAR-T细胞治疗的研发生物技术公司，我们的目标是探索并提供安全、有效和精确的免疫疗法给绝望的癌症患者。我们保证用我们所有的智慧和努力去帮助人们战胜癌症。我们探索每一个提高癌症患者生活质量和生存质量的潜力，减轻他们的痛苦和绝望。
Novel comprehensive cell based immunotherapy platform
创新的基于细胞的免疫治疗平台
 
CAR-T technology progresses slowly on treatment patients with solid tumors. To benefit more patients, we are developing novel comprehensive cell based immunotherapy. We constructed super-vectors to enable the engineered T cells to be more efficient on solid tumors by promoting T cells with better maintenance of memory phenotype. It also authorizes T cells to express immune checkpoint inhibitors, and enhancing the capabilities of T cell homing to the tumor sites.
 
CAR-T技术在治疗病人的肿瘤上进展缓慢。为了使更多的病人受益，我们正在开发新的基于细胞的免疫疗法。我们构建了超级载体，使T细胞能够更好地维护记忆显型，从而使T细胞在实体肿瘤上更有效率。它还授权T细胞表达免疫检查点抑制剂，并提高T细胞在肿瘤位点上的能力。
Anti developing platform
抗体开发平台
 
To facilitate CAR development, we have strong expertise and have established several novel anti developing platforms, including hybridoma generation, physical and bio-functional screening, and anti sequencing technologies et al. The anti developing platforms continually support our fast and innovative CAR technology development and translation.
为促进CAR-T的发展，我们拥有强大的专业知识并建立了几个新的抗体发展平台，包括混合性世代，物理和生物功能筛选，以及抗体测序技术等，抗体开发平台不断支持我们的快速和创新的CAR-T技术开发和转化。